Physician profile
Katherine Grace Epps
NPI 1851888473
$2,755.99
in general payments reported to CMS, 2019-2025
22 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $475 · 2022: $646 · 2023: $731 · 2024: $667 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,634.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $530.27 | 2022-2025 | |
| Novo Nordisk INC | $253.11 | 2021-2024 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $206.48 | 2021-2025 | Airsupra |
| Genzyme Corporation | $199.96 | 2023 | |
| Vanda Pharmaceuticals INC. | $195.21 | 2023-2024 | Fanapt, Hetlioz, Ponvory |
| Medtronic, INC. | $149.89 | 2023 | Corevalve Evolut R |
| Regeneron Healthcare Solutions, INC. | $149.29 | 2021-2022 | |
| Abiomed | $138.30 | 2024 | Impella |
| Livanova USA, INC. | $118.31 | 2022 | |
| Mylan Specialty L.P. | $116.71 | 2021 | |
| Chiesi USA, INC. | $115.43 | 2023 | Cleviprex |
| Biohaven Pharmaceutical Holding Company LTD. | $111.17 | 2022 | |
| Sumitomo Pharma America, INC. | $104.69 | 2023 | Gemtesa |
| Fisher & Paykel Healthcare INC | $93.57 | 2021 | |
| Acclarent, INC | $71.64 | 2022-2023 | Relieva Spinplus |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $61.13 | 2022-2024 | Zepbound, Jardiance |
| Otsuka America Pharmaceutical, INC. | $47.13 | 2025 | Rexulti |
| Organon LLC | $23.97 | 2023 | Nexplanon |
| Optinose US, INC. | $20.38 | 2025 | |
| Mayne Pharma Commercial LLC | $18.01 | 2025 | |
| Genentech USA, INC. | $15.98 | 2021 | |
| Exact Sciences Corporation | $15.36 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Epps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.